RCUS EBITDA Growth
Arcus Biosciences Inc · EBITDA Growth
RCUS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-48.58%period ending
RCUS TTM EBITDA YoY % (-0.72% → -48.58%)
Year-over-year change
High-resolution chart · PNG
RCUS ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -48.5816% | |
| 12.4668% | |
| -17.1004% | |
| -25.6809% | |
| -20% | |
| -74.537% | |
| 7.5601% | |
| 7.3767% | |
| 14.0667% | |
| 18.6343% | |
| -13.4644% | |
| -403.5855% | |
| -453.3863% | |
| -500.7972% | |
| -524.3208% | |
| 133.3387% | |
| 139.7697% | |
| 140.419% | |
| 150.5825% | |
| -218.8831% | |
| -75.4802% | |
| -72.9966% | |
| -40.3625% | |
| -6.141% | |
| -58.8511% | |
| -67.6193% | |
| -66.2877% | |
| -58.0861% | |
| -11.747% | |
| 0.0124% | |
| -0.7181% |